Terms: = Thyroid cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534
7 results:
1. Occupational and patients effective radiation doses in dental imaging.
Tamam N; Almuqrin AH; Mansour S; Elnour A; Musa M; Omer H; Sulieman A; Bradley DA
Appl Radiat Isot; 2021 Nov; 177():109899. PubMed ID: 34438276
[TBL] [Abstract] [Full Text] [Related]
2. Dysregulation of cancer genes by recurrent intergenic fusions.
Yun JW; Yang L; Park HY; Lee CW; Cha H; Shin HT; Noh KW; Choi YL; Park WY; Park PJ
Genome Biol; 2020 Jul; 21(1):166. PubMed ID: 32631391
[TBL] [Abstract] [Full Text] [Related]
3. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract] [Full Text] [Related]
4. miR-17-5p suppresses cell proliferation and invasion by targeting etv1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract] [Full Text] [Related]
5. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary thyroid cancer.
Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
[TBL] [Abstract] [Full Text] [Related]
6. COP1, the negative regulator of etv1, influences prognosis in triple-negative breast cancer.
Ouyang M; Wang H; Ma J; Lü W; Li J; Yao C; Chang G; Bi J; Wang S; Wang W
BMC Cancer; 2015 Mar; 15():132. PubMed ID: 25884720
[TBL] [Abstract] [Full Text] [Related]
7. Concerted activation of ETS protein er81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.
Goel A; Janknecht R
J Biol Chem; 2004 Apr; 279(15):14909-16. PubMed ID: 14747462
[TBL] [Abstract] [Full Text] [Related]
